News
BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
5d
InvestorsHub on MSNPfizer and BioNTech Receive Positive EMA Backing for Updated COVID VaccinePfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...
Moderna said Friday that Pfizer and BioNTech's vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax. The company ...
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine A COVID-19 testing site in Miami Beach, Florida | AFP-JIJI By Julie Steenhuysen and Michael Erman Reuters SHARE/SAVE ...
Coronavirus How BioNTech's husband-and-wife team developed Pfizer's vaccine A Lancet article about a mysterious virus in Wuhan in January inspired the couple ...
Pfizer and BioNTech have a $1.95 billion contract with the U.S. government to deliver 100 million vaccine doses beginning this year. They have also reached supply agreements with the European ...
Pfizer Inc. and BioNTech SE’s COVID-19 vaccine was overwhelmingly effective against the virus in a study that followed nearly 1.2 million people in Israel, results that public-health experts ...
FRANKFURT/ZURICH (Reuters) -BioNTech is testing the effectiveness of the COVID-19 vaccine it developed with Pfizer against a highly infectious new strain of the coronavirus as it prepares to send ...
Vials of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine are pictured in Lansdale, Pennsylvania, U.S., December 5, 2021. REUTERS/Hannah Beier By Ludwig Burger and Michael Erman ...
Germany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2, BioNTech and its partner Pfizer said in a statement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results